86% of physicians responding to a new US survey say they want to be notified before a patient is switched to a different biologic product than the one prescribed, even if there are no known concerns associated with it.

And 85% of physicians responding to the poll said that they want to have the authority to designate a biologic drug as “Dispensed as Written,” just as they have it for chemical drugs.

Read the full story.